PubRank

A L Petzer

Author PubWeight™ 23.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000 3.18
2 C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect Immun 1989 1.76
3 Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A 1997 1.29
4 Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol 2007 1.20
5 Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 2005 1.16
6 Hematopoietic stem cells. Biomed Pharmacother 2001 0.97
7 Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol 2001 0.93
8 Cellular determinants affecting the rate of cytokine in cultures of human hematopoietic cells. Biotechnol Bioeng 1997 0.91
9 Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol 1993 0.89
10 BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia. Blood 1996 0.88
11 Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Ann Oncol 2013 0.87
12 Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res 2001 0.86
13 Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Immunology 1988 0.85
14 Differences between normal and CML stem cells: potential targets for clinical exploitation. Stem Cells 1998 0.81
15 Circulating endothelial cells after transplantation. Lancet 2001 0.81
16 Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2001 0.79
17 Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000. Clin Cancer Res 2001 0.76
18 Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes. Biol Blood Marrow Transplant 2004 0.76
19 Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol 2000 0.76
20 Space flight and growth factors. Lancet 1999 0.76
21 Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2001 0.76
22 Vascular endothelial growth factor platelet counts and renal cancer. Lancet 1999 0.75
23 Correspondence re: P. Salven et al., leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res., 5: 487-91, 1999. Clin Cancer Res 1999 0.75
24 Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Exp Hematol 1993 0.75
25 Aspergillus osteoarthritis in acute lymphoblastic leukemia. Ann Hematol 1999 0.75